These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35220308)

  • 21. Physician experience with once-weekly somatrogon versus once-daily rhGH regimen in pediatric patients with growth hormone deficiency: a cross-sectional survey of physicians from the global phase 3 study.
    Gomez R; Lamoureux R; Turner-Bowker DM; Loftus J; Maghnie M; Miller BS; Polak M; Yaworsky A
    Front Endocrinol (Lausanne); 2023; 14():1254424. PubMed ID: 37955005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations.
    Christiansen JS; Backeljauw PF; Bidlingmaier M; Biller BM; Boguszewski MC; Casanueva FF; Chanson P; Chatelain P; Choong CS; Clemmons DR; Cohen LE; Cohen P; Frystyk J; Grimberg A; Hasegawa Y; Haymond MW; Ho K; Hoffman AR; Holly JM; Horikawa R; Höybye C; Jorgensen JO; Johannsson G; Juul A; Katznelson L; Kopchick JJ; Lee KO; Lee KW; Luo X; Melmed S; Miller BS; Misra M; Popovic V; Rosenfeld RG; Ross J; Ross RJ; Saenger P; Strasburger CJ; Thorner MO; Werner H; Yuen K
    Eur J Endocrinol; 2016 Jun; 174(6):C1-8. PubMed ID: 27009113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies.
    Luo X; Hou L; Liang L; Dong G; Shen S; Zhao Z; Gong CX; Li Y; Du ML; Su Z; Du H; Yan C
    Eur J Endocrinol; 2017 Aug; 177(2):195-205. PubMed ID: 28566441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of long-acting growth hormone replacement therapy in adult growth hormone deficiency: Comparison between adolescent, adult, and elderly patients.
    Kargi AY
    Best Pract Res Clin Endocrinol Metab; 2023 Dec; 37(6):101825. PubMed ID: 37802712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of long-acting growth hormone treatment on endogenous growth hormone secretion in prepubertal patients with idiopathic short stature: A preliminary study.
    Choi HS; Kwon A; Suh J; Song K; Chae HW; Kim HS
    Growth Horm IGF Res; 2022 Oct; 66():101486. PubMed ID: 35868146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Cell-Based Strategy for Bioactivity Determination of Long-Acting Fc-Fusion Recombinant Human Growth Hormone.
    Yao W; Yu L; Fan W; Shi X; Liu L; Li Y; Qin X; Rao C; Wang J
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30970583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GH and IGF-1 Replacement in Children.
    Pfäffle R; Kiess W
    Handb Exp Pharmacol; 2020; 261():67-86. PubMed ID: 31932988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adult growth hormone deficiency: clinical advances and approaches to improve adherence.
    Yuen KCJ; Llahana S; Miller BS
    Expert Rev Endocrinol Metab; 2019 Nov; 14(6):419-436. PubMed ID: 31721610
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of growth hormone in children.
    Hindmarsh PC; Dattani MT
    Nat Clin Pract Endocrinol Metab; 2006 May; 2(5):260-8. PubMed ID: 16932297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rationale for the treatment of short stature in children with the combination of recombinant human growth hormone (rhGH) and recombinant human insulin-like growth factor-I (rhIGF-I).
    Bright GM; Fierro-Renoy JF
    Growth Horm IGF Res; 2020 Jun; 52():101318. PubMed ID: 32252003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and Effectiveness of Omnitrope®, a Biosimilar Recombinant Human Growth Hormone: More Than 10 Years' Experience from the PATRO Children Study.
    Pfäffle R; Bidlingmaier M; Kreitschmann-Andermahr I; Land C; Partsch CJ; Schwab KO; Sommer H; Backeljauw P; Kanumakala S; Loche S; Zouater H; Strasburger CJ
    Horm Res Paediatr; 2020; 93(3):154-163. PubMed ID: 32814319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacokinetic and pharmacodynamic properties and short-term outcome of a novel once-weekly PEGylated recombinant human growth hormone for children with growth hormone deficiency.
    Liang Y; Zhang C; Wei H; Du H; Zhang G; Yang Y; Zhang H; Gong H; Li P; Song F; Xu Z; He R; Zhou W; Zheng H; Sun L; Luo X
    Front Endocrinol (Lausanne); 2022; 13():922304. PubMed ID: 36034448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-acting recombinant human growth hormone in the treatment of pediatric growth hormone deficiency, how far have we got?
    Bouhours-Nouet N; Teinturier C
    Arch Pediatr; 2022 Feb; 28(8S1):8S14-8S20. PubMed ID: 37870528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and effectiveness of Omnitrope
    Backeljauw P; Kanumakala S; Loche S; Schwab KO; Miller BS; Levy R; McCormick K; Zouater H; Zabransky M; Campbell K
    Eur J Pediatr; 2022 Jun; 181(6):2367-2378. PubMed ID: 35275291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study.
    Deal CL; Steelman J; Vlachopapadopoulou E; Stawerska R; Silverman LA; Phillip M; Kim HS; Ko C; Malievskiy O; Cara JF; Roland CL; Taylor CT; Valluri SR; Wajnrajch MP; Pastrak A; Miller BS
    J Clin Endocrinol Metab; 2022 Jun; 107(7):e2717-e2728. PubMed ID: 35405011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.
    Hou L; Liang Y; Wu W; Lin HH; Luo XP; Ying YQ
    Growth Horm IGF Res; 2020; 53-54():101331. PubMed ID: 32777706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children.
    Hou L; Chen ZH; Liu D; Cheng YG; Luo XP
    Drug Des Devel Ther; 2016; 10():13-21. PubMed ID: 26719670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The adult growth hormone multicentric retrospective observational study: a 24-month Italian experience of adherence monitoring via Easypod™ of recombinant growth hormone treatment in adult GH deficiency.
    Mancini A; Vergani E; Bruno C; Giavoli C; Spaziani M; Isidori AM; Arosio M; Pontecorvi A
    Front Endocrinol (Lausanne); 2023; 14():1298775. PubMed ID: 38027149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.